| Literature DB >> 27557088 |
Ruben Geevarghese1,2, Daniel E Lumsden3, Angela Costello4, Natasha Hulse5, Salma Ayis6, Michael Samuel5, Keyoumars Ashkan1,7.
Abstract
BACKGROUND: Parkinson's disease is a chronic degenerative movement disorder. The mainstay of treatment is medical. In certain patients Deep Brain Stimulation (DBS) may be offered. However, DBS has been associated with post-operative neuropsychology changes, especially in verbal memory.Entities:
Mesh:
Year: 2016 PMID: 27557088 PMCID: PMC4996448 DOI: 10.1371/journal.pone.0160583
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Patient Demographics.
| Patient Demographic | |
|---|---|
| Gender | 17 female and 23 male |
| Handedness | 38 right handed and 2 left-handed |
| Age at surgery (mean ± SD) | 60.2 ± 7.2 years old |
| Age of onset (mean ± SD) | 48.4 ± 8.7 years old |
| Duration of illness (mean ± SD) | 11.9 ± 5.0 years |
| UPDRS Part III Score (mean ± SD) | 39.2 ± 19.1 |
Summary of patient demographics. UPDRS Part III score was not available for 2 patients.
Fig 1Brain MR images.
Axial (top) and coronal (bottom) Brain MR image before (left) and after (right) application of FIRST. The colours correspond to the segmented sub-cortical structures: pink (left hippocampus), light blue (right hippocampus), orange (left thalamus) and purple (right thalamus).
Neuropsychology test score decline.
| Neuropsychology test | Mean Score Change | S.D. | Wilcoxon signed rank test (p value) |
|---|---|---|---|
| Delayed Story Recall (n = 38) | -1.68 | ±2.74 | 0.01 |
| Immediate Story Recall (n = 40) | -1.93 | ±2.72 | <0.01 |
| List Learning (n = 40) | -1.43 | ±2.19 | 0.02 |
Mean score change, standard deviation and the associated p-value, for each test, obtained from Wilcoxon signed rank test.
* Full Delayed Story Recall data was not available for two patients.
Linear modelling of change in test scores with volumetric and clinical data.
| Change in test score | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Predictors | |||||||||
| 9.37 | 4.80 | 0.06 | 5.57 | 3.76 | 0.15 | 4.97 | 4.72 | 0.30 | |
| 7.12 | 4.90 | 0.16 | 8.84 | 3.74 | |||||
| 0.12 | 0.09 | 0.19 | -0.16 | 0.67 | |||||
| -0.08 | 0.06 | 0.18 | |||||||
| 9.62 | 5.22 | 0.07 | 4.98 | 4.08 | 0.23 | 4.36 | 5.11 | 0.40 | |
| 6.86 | 5.39 | 0.21 | 4.16 | 8.36 | 0.05 | ||||
| 0.12 | 0.09 | 0.19 | -0.16 | 0.07 | |||||
| -0.08 | 0.06 | 0.19 | |||||||
| 16.90 | 8.80 | 0.06 | 12.10 | 6.82 | 0.09 | 11.87 | 8.58 | 0.18 | |
| 12.58 | 8.92 | 0.17 | 16.13 | 6.72 | |||||
| 0.13 | 0.09 | 0.15 | -0.15 | 0.07 | |||||
| -0.07 | 0.06 | 0.23 | |||||||
| 9.06 | 9.79 | 0.36 | 11.76 | 7.21 | 0.11 | 8.43 | 9.14 | 0.36 | |
| 4.25 | 9.76 | 0.67 | 15.91 | 7.12 | |||||
| 0.15 | 0.09 | 0.11 | -0.15 | 0.07 | |||||
| -0.08 | 0.06 | 0.19 | |||||||
Table to show the results of linear modelling investigating the relationship of test score change with volumetric and clinical data. The absolute test score change was used as the outcome variable. In the unadjusted model, the volume of the structure of interest was used as the predictor. In the adjusted model, the volume of the structure of interest and clinical variables, found to be of interest (see S1 Table) for the test in question were chosen as predictors. Significant p-values are highlighted in bold. Duration of symptoms was found to be a significant predictor of change in list learning score. Left thalamic and hippocampal and right hippocampal volumes were also found to be significant predictors of list learning score change in the adjusted models. Age was not a significant predictor of score change in any of the neuropsychological tests.
Volumetric differences between stable and decline performers.
| Comparison of clinical and volumetric parameters between stable and decline performers in Delayed Story Recall (n = 38) | |||
| p-value | |||
| Stable (n = 21) | Decline (n = 17) | ||
| Age at surgery | 61.1 ±7.4 | 58.2 ± 7.05 | 0.15 |
| UPDRS Part III (n = 36) | 36.0 ±15.4 | 40.1 ± 22.3 | 0.66 |
| Duration of symptoms | 12.6 ± 5.4 | 10.0 ± 4.3 | 0.20 |
| Gender (M/F) | 11/10 | 11/6 | |
| Comparison of clinical and volumetric parameters between stable and decline performers in Immediate Story Recall (n = 40) | |||
| p-value | |||
| Stable (n = 22) | Decline (n = 18) | ||
| UPDRS Part III | 39.0 ± 16.6 | 39.3 ± 22.1 | 0.68 |
| Duration of symptoms | 12.7 ±5.4 | 12.2 (±5.6) | 0.95 |
| Gender (M/F) | 12/10 | 11/7 | |
| Left Thalamus | 0.60 ± 0.10 | 0.57 ± 0.08 | 0.27 |
| Right Thalamus | 0.58 ± 0.10 | 0.55 ± 0.07 | 0.26 |
| Left Hippocampus | 0.30 ± 0.05 | 0.27 ± 0.05 | 0.15 |
| Right Hippocampus | 0.30 ± 0.05 | 0.27 ± 0.05 | 0.18 |
| Comparison of clinical and volumetric parameters between stable and decline performers in List Learning test (n = 40) | |||
| p-value | |||
| Stable (n = 30) | Decline (n = 10) | ||
| Age at surgery | 59.7 ± 7.1 | 60.2 ± 8.1 | 0.77 |
| UPDRS Part III | 34.7 ± 15.0 | 51.7 ± 24.3 | 0.07 |
| Gender (M/F) | 14/16 | 9/1 | |
| Left Thalamus | 0.59 ± 0.08 | 0.57 ± 0.13 | 0.25 |
| Right Thalamus | 0.57 ± 0.07 | 0.56 ± 0.12 | 0.35 |
| Left Hippocampus | 0.29 ± 0.04 | 0.27 ± 0.07 | 0.10 |
| Right Hippocampus | 0.29 ± 0.05 | 0.27 ± 0.06 | 0.43 |
Table to show the clinical and volumetric parameters of stable and decline performers in the Story Recall Delayed, Immediate Story Recall and List Learning tests. A Mann-Whitney U Test was used to assess the difference between clinical and volumetric data between groups. Significant values are highlighted in bold.
2 patients were excluded as complete Story Recall Delayed test data was not available